Fusion Genomics Corporation news
The British Columbia-led Digital Technology Supercluster is one of the funding recipients for the Government of Canada’s Innovation Supercluster
We are pleased to share the news that Fusion Genomics has received a $1 million award to conduct a study evaluating our comprehensive, novel ONETest PathoGenome assay for the detection of pathogens associated with respiratory tract infections (RTIs). Due in great part to limitations associated with current diagnostic tests, RTIs are a leading cause of morbidity, mortality, and hospitalizations globally. Faster identification and diagnosis of pathogens responsible for these infections could he
Genome Prairie announced that they are partnering with the Vancouver-based Fusion Genomics Corporation using Fusion Genomics’ ONETest platform, including
FUSION GENOMICS Corporation is a molecular diagnostic company that develops clinical assays using next-generation sequencing technologies to characterize infectious disease agents of clinical and global importance. We are looking to hire a full-time Postdoctoral Fellow to join our team in an exciting and highly dynamic start-up environment.
FUSION GENOMICS